Edgewise Therapeutics

EWTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.682 B

$43.52 -2.03%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$167.8K

Loss-making

Shares outstanding

108,604,129

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#61Indivior PharmaceuticalsINDV$4.84B
#62VeradermicsMANE$4.78B
#63Edgewise TherapeuticsEWTX$4.68B
#64Enliven TherapeuticsELVN$4.43B
#65Parabilis MedicinesPBLS$4.15B

Where these numbers come from

Share counts and financials for Edgewise Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.